Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Effect of an Antioxidant Dietary Supplement on Skin Radiance

NCT07793123 · tracked via the Priya Life Science France tracker
Sponsor
Robertet SA
Phase
Not applicable
Started
2026-08-31
Last updated
2026-09-16

Condition(s) studied

Healthy Women

Investigational drug(s) / intervention(s)

Antioxidant SupplementPlacebo

Antioxidant Supplement: Oral antioxidant dietary supplement administered as one capsule once daily for 90 days.

Placebo: Placebo dietary supplement administered as one capsule once daily for 90 days.

Study summary

A randomized, double-blind, placebo-controlled study evaluating the effects of an oral antioxidant dietary supplement on skin radiance in women exposed to urban air pollution. Secondary assessments include skin tone homogeneity, pigmentation, inflammation, skin barrier function, glycation markers.

Eligibility

Sex
FEMALE
Min age
35 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy female subjects aged 35 to 65 years. * Fitzpatrick skin phototype II to IV. * Any skin type. * Dull and uneven skin complexion. * Living in an urban environment and exposed to pollution. * No change in hormonal treatment within the past 3 months. * Able to understand the study procedures and provide informed consent. * Willing and able to comply with study requirements. * Written informed consent obtained. * Covered by health insurance. * Willing to avoid unprotected sun exposure and use SPF 50 sunscreen throughout the study. Exclusion Criteria: * Pregnant or breastfeeding women, or women planning to become pregnant during the study. * Current use of dietary supplements or vitamin supplements. * Participation in another clinical trial involving a cosmetic product, drug, or medical device. * Use of oral or injectable corticosteroids within the past 3 months. * Current treatment with immunosuppressive agents, chemotherapy, or radiotherapy. * History of autoimmune disease or connective tissue disorder. * Presence of an active dermatological condition that could affect study assessments. * Following a vegetarian, vegan, or weight-loss diet. * Not covered by health insurance. * Participation in another clinical study during the exclusion period. * Individuals considered vulnerable according to applicable regulations.

Primary outcome measure(s)

  • Skin Radiance — Day 0 and Day 90
    Glossymeter

Trial sites (1)

FacilityCityRegionStatus
Gredeco Paris France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07793123 on ClinicalTrials.gov ↗ ← All trials in France